The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 6,627 |
| Provision for doubtful accounts | 200 |
| Depreciation | 12,374 |
| Loss on disposal of and reserve adjustments for medical equipment | 519 |
| Gain on sale of medical equipment | 3,308 |
| Amortization of intangible assets | 920 |
| Amortization of deferred debt issuance costs | 81 |
| Stock-based compensation | 4,363 |
| Deferred income taxes | 2,726 |
| Accounts receivable | -263 |
| Inventories | -1,140 |
| Other current assets | 903 |
| Other assets | -114 |
| Accounts payable and other liabilities | -708 |
| Net cash provided by operating activities | 24,408 |
| Acquisition of business | 1,412 |
| Purchase of medical equipment | 8,126 |
| Purchase of property and equipment | 560 |
| Proceeds from sale of medical equipment, property and equipment | 3,308 |
| Net cash used in investing activities | -6,790 |
| Principal payments on long-term debt | 52,349 |
| Cash proceeds from long-term debt | 48,226 |
| Debt issuance costs | 197 |
| Common stock repurchased as part of share repurchase program | 9,869 |
| Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans | 1,105 |
| Cash proceeds from exercise of options and espp | 335 |
| Net cash used in financing activities | -14,959 |
| Net change in cash and cash equivalents | 2,659 |
| Cash and cash equivalents, beginning of period | 527 |
| Cash and cash equivalents, end of period | 3,186 |
InfuSystem Holdings, Inc (INFU)
InfuSystem Holdings, Inc (INFU)